Healthcare Resource Guide: Saudi Arabia

Saudi Arabia

Statistics


Summary

Policy Issues

Market Entry

Current Market

Trends

Main Competitors

Current Demand

Registration Process

Barriers

Reimbursement

Government Procurement

Trade Events

FAQs

Best Prospects

CS Contacts

Market Size

Capital: Riyadh

Population: 33.6 million (2018)

GDP: $683.83 Billion (2018)

Currency: Saudi Riyals (US$1 = SAR 3.75)

Language: Arabic (official); English (widely spoken)

Summary

The Saudi healthcare sector is the largest in the Near East. Education and healthcare spending still accounts for the largest share of the Saudi 2018 budget, at more than 36% of the total budget. With the drop in oil revenues, however, the Saudi Government scaled back the levels of spending across the board. However, the budget for healthcare and social development increased nearly 10% in 2018 to reach a total of $39.2 billion. Public spending still dominates at 79%, though the private sector is quickly catching up and growing at a faster pace, mainly due to the launch of the National Transformation Program (NTP) in 2016, which aims, among other objectives, to expand the privatization of government services, including healthcare.

Saudi Arabia's healthcare landscape will continue to evolve as the government pursues reforms in the sector. Boosting health privatization initiatives will be a central part of the Kingdom's economic diversification efforts, intended to reduce its dependence on the public sector. The healthcare sector contributed $20.8 billion to the Kingdom’s GDP in 2015. The sector is projected to grow by 13.7% by 2025. Recently, the government decided to privatize all its public hospitals and introduce Public-Private Partnership programs, as included in the government’s NTP 2020 objectives:

  • To expand the role of the private sector from 25% to 35% by 2020
  • To increase the number of licensed medical facilities from 40 to 100
  • To increase the number of internationally accredited hospitals
  • To double the number of primary care centers visits per capita from two to four
  • To decrease the percentage of smoking and obesity by establishing a strategy focused on preventive medicine and advocate for a healthy lifestyle and wellness
  • To focus on digital health

Imports of medical devices accounted for more than 98% of the market at $1.8 billion, and American companies top the list of suppliers with a 21% share of total imports. Local manufacturing is still limited to consumables, including bandages, gloves, syringes, and some furniture including non-electrical beds. The NTP envisages boosting and supporting local manufacturing through foreign investments in the healthcare sector, especially for pharmaceuticals and medical devices.

The Kingdom of Saudi Arabia accounts for 59.4% of the purchases of pharmaceutical products in the Arabian Gulf and will remain a key market for many leading multinational pharmaceutical companies in the Near East. In addition to the demographic and epidemiological driving factors, the transition to an increasingly privatized and comprehensive healthcare system will drive the demand for both patented and generic drugs.

Spending on the Health IT sector is also expected to maintain positive growth, especially the government’s resolve to finalize various projects including the standard e-Health card, patient digital records, doctors’ prescriptions, and insurance claims. Industry sources estimate annual spending on modernizing and upgrading the e-Health infrastructure at $500 million, likely to double in the years ahead, budget permitting. One of the NTP’s objectives is to increase the percentage of patients with a digital health record from 0% to 70% by 2020.

Vison 2030 & National Transformation Program (NTP)

The Government of Saudi Arabia seeks to expand the private sector’s role in providing healthcare services under its Vision 2030 and its National Transformation Program. Some goals include plans to expand the privatization of government services, incorporate health IT and digital records, double the number of qualified Saudi nurses by 2020, and increase the number of licensed medical facilities from 40 to 100 by 2020.

Healthcare Policy Issues

The Kingdom of Saudi Arabia seeks to expand the private sector’s role in providing healthcare services under its ambitious Vision 2030 and its National Transformation Program. Saudi Arabia’s deteriorating environment for intellectual property protections in pharmaceuticals, however, dampens the positive signals sent to entrepreneurs, investors, and innovators in the private sector. Due to unresolved intellectual property infringement issues impacting innovative pharmaceutical companies, Saudi Arabia is on the Watch List of USTR’s Special 301 Report, which was released in April 2018.

Market Entry

Although American exporters are not required to appoint a local Saudi agent or distributor to sell to Saudi companies, it is strongly recommended that all new-to-market U.S. companies consider partnering with a local company for the purposes of monitoring business opportunities, navigating import and standard testing regulations, and identifying public sector sales and contract opportunities.

The U.S. Department of Commerce in Saudi Arabia regularly assists U.S. companies identify market opportunities and qualified business partners. It also provides advocacy and commercial diplomacy services to U.S. firms and promotes greater transparency in commercial matters and public procurement by engaging Saudi regulatory and standards bodies and Saudi public institutions.

Imported medical devices are charged a 5% customs duty; in some instances, however, imported equipment is exempt from this duty, notably if the shipment is bound for a government entity and/or a government project. Additionally, and as of January 1, 2018, a 5% VAT was introduced on all goods and services that are bought or sold by businesses with a few exceptions. The General Authority of Zakat & Tax has exempted medicine and medical devices of the VAT for “only those items that are specified/procured by the Ministry of Health and the Saudi Food and Drug Authority.”

Shipping: Saudi Arabia gives preference to national carriers for up to 40% of government-related cargos. Two local companies take full advantage of this situation.

Standards and labeling: As part of the GCC Customs Union, the six Member States are working toward unifying their standards and conformity assessment systems. However, each Member State continues to apply its own standard or a GCC standard. A new ICCP mandates that a Certificate of Conformity must accompany all consumer goods exported to Saudi Arabia. Labeling and marking requirements are compulsory for any products exported to Saudi Arabia. The Saudi Arabian Standards Organization (SASO) is responsible for establishing labeling and other guidelines. The Ministry of Commerce and Investment implements SASO guidelines through its inspection and test laboratories at Saudi ports of entry.

Current Market Trends

Based on data from industry and the World Health Organization (WHO), Saudi Arabia, like other countries in the Arabian Gulf, continues to exhibit lifestyle change trends within its morbidity statistics. Non-communicable diseases, such as diabetes, cardiovascular diseases and cancer have become the main causes of death, estimated to account for more than 78% of total deaths. Additionally, the Kingdom has one of the world’s highest rates of traffic accidents, ranked at 23rd globally with a car accident occurring every second, while 17 people are killed in crashes every day on average.

Saudi Arabia, like other countries in the Arabian Gulf, continues to exhibit negative lifestyle trends which are affecting morbidity statistics. Non-communicable diseases such as diabetes, cardiovascular disease and cancer have become the main causes of death among Saudis; their incidence is rising due to a sedentary lifestyle, obesity, high tobacco use, and poor dietary choices. Type-2 diabetes has a 14.4% prevalence rate and 2.5 million people are expected to be diabetic by 2030. The latest World Health Organization (WHO) figures indicate that 33.7% of Saudi adults are obese and 68.2% are overweight.

The demand for healthcare products and services is mainly driven by government initiatives and affluent lifestyle changes. According to the International Diabetes Federation, Saudi Arabia has an 18.5% prevalence rate, with 3.85 million cases of diabetic adults in 2017. The British medical journal, the Lancet, has placed Saudi Arabia in third position worldwide in terms of obesity, and the latest figures from the medical community indicated that Saudi Arabia has one of the highest percentage of bariatric procedures including sleeve gastrectomy, gastric bypass, and the placement of gastric band.

In turn, those figures have been the key drivers for various equipment and services, namely:

  • Emergency & trauma equipment
  • Rehabilitation equipment
  • Diagnostic equipment
  • Electro-medical equipment
  • Hospital beds
  • Orthopedic appliances and prosthesis
  • Dental equipment
  • Laboratory equipment
  • Hospital operation and management
  • E-Health
  • Generic pharmaceuticals

The public sector dominates the supply of healthcare services in Saudi Arabia and accounts for the majority of healthcare expenditures. The public healthcare sector represents approximately 79% of bed capacity. Industry sources expect the private sector to grow at a faster pace than the government sector, enhanced by the latest government policies to encourage more private sector involvement in the provision of healthcare services. The latest figures suggest that the MoH bed capacity will almost reach 73,768 beds by 2020; the private sector will add 13,875 beds raising its capacity to 26,000 by 2020, while other government organizations will total 20,000 beds in 2020.

The number of hospital beds currently stand at 68,000 for all hospitals in Saudi Arabia the number is expected to grow to 119,000 beds by 2020. Moreover, a private group of investors is developing Riyadh’s Medical Village over a 250,000 sq. meter area, consisting of eight 130-bed hospitals, 60 outpatient clinics, and other amenities and services. Currently, the healthcare budget stipulates the construction of 36 new hospitals (8,950 beds) and two medical cities (2,350 beds) that are expected to be completed by the end of 2018. The Ministry is expected to build an additional 18 hospitals with a bed capacity of 9,904 over the next two years.

Notwithstanding, the Saudi Government’s NTP’s five-year plan (2016-2020), which stipulates the following objectives:

  • To expand the role of the private sector from 25% to 35% of total healthcare expenditures
  • To increase the number of licensed medical facilities from 40 to 100
  • To increase the number of internationally accredited hospitals
  • To double the number of primary healthcare visits per capita from two to four
  • To decrease the percentage of smoking and obesity by 2% and 1% from baseline respectively
  • To double the percentage of patients receiving healthcare after critical care and long-term hospitalization within four weeks from 25% to 50%
  • To focus on improving the quality of preventive and therapeutic healthcare services; and,
  • To increase the focus on digital healthcare innovations

Main Competitors

The Saudi market is completely dependent on imports for medical devices; U.S. suppliers enjoy some advantages, including competitive prices, language, and exchange rate. European suppliers are aggressively gaining market share due to their close proximity to the market, and perceived better customer support.

On the other hand, the pharmaceuticals sector is characterized by a growing domestic manufacturing base, mainly for generic and OTC drugs, as well as licensing arrangements with branded research-based foreign innovative drug manufacturing firms.

The Saudi domestic pharmaceutical industry lacks R&D capabilities, and it remains focused on producing basic formulations of off-patent preparations to feed into the generics market. The lack of R&D is compounded by an unpredictable IPR regulatory system and, recently a vague pricing structure, which is affecting the introduction of many new research-based products into the market.

Nonetheless, government policies are biased in favor of domestic producers, providing them with exemptions, including interest-free funding, subsidized utility charges, and no import duties on raw materials and intermediate products.

Industry sources project domestic production to contribute 40% of the market by 2020 in line with the National Transformation program objectives to localize the industry.

Current Demand

The demand for healthcare services has continuously outpaced supply and both the public and private sectors are struggling to accommodate growing demand. A growing population, compulsory health insurance coverage, and the prevalence of diseases are serving to boost the demand for services and hospital bed occupancy. According to the Council of Cooperative Health Insurance (CCHI) and the 2018 Knight Frank report, 27 insurance companies are operating in the Kingdom with around 11 million beneficiaries including Saudis and expatriates, the overwhelming majority of which account for the latter. The insurance reform, however, could swell the pool with more than a million Saudi civil servants plus about 5 million dependents. Gross premiums reached $5 billion in 2015, 20% more than in 2014.

Additionally, the Executive Board of the Health Ministers’ Council for the GCC states (HO in Riyadh) release an annual tender valued at several billions of dollars for the following items:

  • Hospital sundries
  • Renal Dialysis supplies
  • Oral & dental care
  • Laboratory sundries
  • Orthopedic & spinal surgery
  • Rehabilitation
  • Cardiovascular
  • Linens & medical uniforms
  • Ophthalmology sundries
  • ENT sundries
  • Medicines
  • Vaccines
  • Chemicals
  • Insecticides
  • Radio-pharmaceuticals
  • Renal dialysis solutions

Major players in the Saudi healthcare sector include:

  • Ministry of Health
  • Saudi Arabian National Guard
  • King Faisal Specialist Hospital and Research Center
  • Ministry of Defense & Aviation
  • Ministry of Education
  • Ministry of Interior
  • John Hopkins Aramco Healthcare
  • Private Sector
  • Executive Board of the Health of the Health Ministers Council for the GCC States

Registration Process

The Saudi Food & Drug Authority (SFDA) monitors and controls the import and distribution of medical devices, pharmaceuticals, and food products. For medical devices, the SFDA will usually accept, register, and authorize the marketing and sale of any device that complies with applicable provisions of the SFDA‘s Interim Regulations and relevant regulatory requirements

applicable in one or more of the countries of the Global Harmonization Task Force (GHTF), which includes Australia, Canada, Japan, USA, and EU/EFTA. More information on the registration process can be found at https://www.sfda.gov.sa/en/pages/default.aspx

Reimbursement

The Ministry of Health (MOH) is the major government agency entrusted with the provision of preventive, curative and rehabilitative healthcare for the Kingdom’s population. The Ministry provides primary healthcare (PHC) services through a network of healthcare centers throughout the kingdom. It also adopts the referral system which provides curative care for all members of society from the level of general practitioners at health centers to advanced technology specialist curative services through a broad base of general and specialist hospitals. The MOH also undertakes the overall supervision and follow-up of healthcare related activities carried out by the private sector. Therefore, the MOH can be viewed as a national health service (NHS) for the entire population.

The private sector provides health services through its health facilities including hospitals, dispensaries, laboratories, pharmacies and physiotherapy centers throughout the kingdom. Saudis and public sector expats are eligible for a comprehensive package of benefits including, public health, preventive, diagnostic, and curative services and pharmaceuticals with few exclusions and no cost sharing. Most services including state of the art cardiovascular procedures, organ transplants, and cancer treatments (including bone marrow transplants) are covered. Sponsors/employers are responsible for paying for an extensive package of services for private sector expatriates. In 2005, health insurance was made compulsory for all non-Saudi nationals working in the country under the Cooperative Health Insurance Act. In 2008, this act was extended to include Saudi nationals working for the private sector. Enforcements of this compulsory coverage include fines for non-compliant companies and a refusal to renew working permits without insurance. By mid-2017, mandatory health insurance for all Saudi and non-Saudi employees and their families in the private sector became effective as the Government is moving towards privatizing the healthcare care services. The MOH plans to privatize all its services through the National Transformation Program 2020 which will increase the private sector contribution to the health sector from 25-35% and change government hospitals to semi-public companies. As a result of this privatization program, around 20 million Saudi citizens will need insurance coverage by 2020.

Delayed Payments: Companies who have significant experience with government contracts here report they have carried SAG receivables for years. The problem has become more visible following the sustained decline in oil prices over the last three years and ongoing government austerity measures. The SAG continued to delay payments to major contractors throughout 2016, though made progress by setting aside $28 billion and making some payments to clear arrears starting in October 2016. Moreover, on January 20, 2018, the Ministry of Finance launched “Eitimad” a unified digital services platform that allows government entities and private sector contractors to make full use of the Ministry’s advanced procurement e-services, enhancing the speed of process, ensuring accuracy of data and increasing the ease of doing business. However, should payment problems or delays persist, U.S. companies should contact the U.S. Commercial Service at the Embassy in Riyadh or Consulates in Dhahran or Jeddah.

Barriers

  • Commercial Disputes Settlement: Conventionally, dispute settlement in Saudi Arabia has proven to be time-consuming and uncertain. Saudi commercial law is still developing, but in 1994 the Saudis took the positive step of joining the New York Convention of 1958 on the Recognition and Enforcement of Foreign Arbitral Awards. Saudi Arabia is also a member of the International Center for the Settlement of Investment Disputes (also known as the Washington Convention). However, recently the Saudi Government demonstrated several improvements on the quality of commercial legal proceedings and established access to alternative dispute resolution mechanisms. According to the Department of State’s 2017 Investment Climate Statement, following the update of certain provisions in Saudi Arabia’s domestic arbitration law in 2012, it led to the establishment of the Saudi Center for Commercial Arbitration (SCCA) in 2016. Developed in accordance with international arbitration rules and standards, including those set by the American Arbitration Association’s International Centre for Dispute Resolution and the International Chamber of Commerce’s International Court of Arbitration, the SCCA offers comprehensive arbitration services to firms both domestic and international. Awards rendered by the SCCA can be enforced in local courts, though judges remain empowered to reject enforcement of provisions they deem non-compliant with sharia law.
  • Business Visas: Saudi Arabia has begun to implement a decree stating that sponsorship for certain business visas is no longer required. Based on new instructions, the issuance of a visitor’s visa should be affected within 24 hours from the visa application date. While most business visas are valid for only one entry for a period of up to three months, the Saudi Embassy in Washington has begun issuing a 5-year multiple entry visa for selected business people, taking into consideration the principle of reciprocity—yet visa fees are considered costly. Finally, the Saudi Ministry of Foreign Affairs has recently issued a visitor’s visa at ports of entry for selected nationalities.
  • Intellectual Property Protection: In a recent move to demonstrate Saudi Arabia’s commitment to intellectual property protection, the Saudi Government announced the establishment of the Saudi Intellectual Property Authority (SIPA) and launched the strategy of SIPA under the umbrella of Ministry of Commerce and Investment (MCI) in April 2018. Prior to that, Saudi Arabia recently undertook a comprehensive revision of its laws covering intellectual property rights to bring them in line with the WTO agreement on Trade Related Aspects of Intellectual Property Rights (TRIPs). The Saudi legal system protects and facilitates acquisition and disposition of all property rights, including intellectual property. The Saudi Government recently updated the Trademark Law (2002), the Copyright Law (2003), and the Patent Law (2004), with the dual goals of TRIPs- compliance and effective deterrence against violators. In 2008, the Violations Review Committee created a website and has populated it with information on current cases. The government also endorsed the country’s joining the “Paris Convention for Protection of Industrial Property” and the “Berne Convention for the Protection of Literary and Artistic Works.” Although intellectual property protection has steadily increased in the Kingdom, intellectual piracy remains a problem. The current Law on Patents, Layout Designs of Integrated Circuits, Plant Varieties and Industrial Designs has been in effect since September 2004. Largely due to a lack of adequate resources and technical expertise, when this law went into effect the Patent Office had issued just over 40 patents and had a large backlog (more than 9,000 applications dating back to issuance of Saudi Arabia’s first patent law in 1989). The office has since streamlined its procedures, hired more staff, and reduced this backlog. Protection is available for product and product-by-process. The term of protection was increased from 15 years to 20 years under the new law, but patent holders can no longer apply for a routinely granted five-year extension. Trademarks are protected under the Trademark Law. The Rules for Protection of Trade Secrets came into effect in 2005. Saudi Arabia has one of the best trademarks laws in the region, and the Saudi Customs Authority took significant enforcement efforts in the past several years. The Saudi Government has revised its Copyright Law, is devoting increased resources to marketplace enforcement, and is seeking to impose stricter penalties on copyright violators. The Saudi Government has stepped up efforts to force pirated printed material, recorded music, videos, and software off the shelves of stores. These efforts included stepping up raids on shops selling pirated goods in 2008. However, due to concerns regarding recent deteriorations in IP protection for pharmaceutical products, in addition to outstanding concerns regarding IP enforcement and the continued use of unlicensed software by the government, Saudi Arabia was placed in the Special 301 Watch List in April 2018. Saudi Arabia has not signed and ratified the WIPO internet treaties.
  • Counterfeiting: Manufacturers of consumer products and automobile spare parts are particularly concerned about the widespread availability of counterfeit products. Anti-counterfeiting laws exist, and the U.S. Government has urged the Saudi authorities to step up enforcement actions against perpetrators. In some popular consumer goods, manufacturers estimate that as much as 50% of the entire Saudi market is counterfeit. In order to restrict the entry of counterfeit products, the Saudi Customs Authority recently implemented a new directive requiring all imported goods to clearly display the “Country of Origin” or “Made in ….” on the items in an irremovable manner either by engraving, knitting, printing, or pressing based on the nature of the imported items. This requirement is strictly enforced. While comprehensive data on seizers of counterfeit goods is not available, the SAG makes public announcements on local and social media when large seizures are made.

Government Procurement

Procurement is subject to the 2006 Government Tenders and Procurement Law and its 2007 implementing regulations. There is no central procurement office. Each ministry or autonomous agency contracts directly with suppliers within the framework of the regulations. However, the Ministry of Finance provides oversight and is required by law to review all contracts valued at 5 million riyals or more and contracts with execution periods of longer than one year.

Under the regulations, all purchases must be made through public tender unless specifically exempted. Tenders are announced in the official gazette, two local newspapers, various electronic media, and foreign media as necessary. Bids may be submitted in sealed envelopes or electronically by the specified date, and they must be accompanied by a bid bond of between 1% and 2% based on the terms of the tender. Bids are valid for 90 days. The regulations require equal treatment of national and foreign goods.

Contracts are generally awarded to the lowest bidder that meets the conditions set forth in the tender; however, if the lowest bid is 35% lower than the purchasing agency's estimates or prevailing market prices the bid must be excluded unless the bidder satisfies the agency that it can perform the obligations of the contract. Bids also may be excluded if the purchasing agency believes that the bidder's contractual obligations would exceed its ability to execute the contract. Once a contract is awarded, the winning bidder must supply a performance guarantee equivalent to 5% of the contract value. Once a contract is awarded, the purchasing authority may increase by up to 10% or decrease by up to 20% the total value of the supplier's obligation, subject to strict criteria.

Bid guarantees and performance guarantees may be in the form of a guarantee from a local bank or a guarantee from a foreign bank submitted through a local bank. Cash guarantees are acceptable only in certain urgent cases. A guarantee is not required for direct purchase contracts unless the purchasing agency deems it necessary. Although Arabic is the official language, English is spoken and understood widely. Firms resident or working in Saudi Arabia must conduct all official business with the government in Arabic. The tender regulations state that bids may be in any language, but in practice, tender announcements generally specify the language of the bid.

Selling to the Government

In Saudi Arabia, every government agency has its own full contracting authority. So, foreign companies interested in bidding on a government project must make themselves known to that specific government agency/ministry offering the project. When a project becomes available, the government agency/ministry selects bidders from a list of prequalified/known companies and invites them to bid for that particular project.

The Saudi Government Contracting and Procurement Law states that all qualified companies and individuals will be given equal opportunities and will be treated equally. The law also affirms that all government bids must be announced in the official gazette Umm al-Qoura (Arabic), in two local newspapers, as well as in electronic media. There is no central tender board in Saudi Arabia except “Monafasat” which is E-Government Procurement project, which is considered one of the projects under the broader e-Government initiative in the Kingdom of Saudi Arabia (http://www.saudiegp.sa/cms/page/key/about_project). There are a number of governmental healthcare purchasing agencies in Saudi Arabia including the Ministry of Health, Ministry of Interior, Ministry of Defense and the Ministry of the National Guard. The Ministry of Finance operates as a central government procurement portal where all government tenders are listed.

The tender regulations require that preferences be given in procurements to Saudi individuals and establishments and other suppliers in which Saudi nationals hold at least 51% of the supplier’s capital. The tender regulations also give a preference to products of Saudi origin that satisfy the requirements of the procurement. In addition, Saudi Arabia gives priority in government purchasing to GCC products. These items receive up to a 10% price preference over non-GCC products in all government procurements in which foreign suppliers participate. In addition, several royal decrees strongly favoring GCC nationals in the award of government procurement contracts have been issued. Foreign suppliers that participate in government procurement are required to establish a training program for Saudi nationals.

Links for Saudi healthcare purchasing agencies:

Trade Events

Name of event: Global Health Exhibition 2018

Dates: September 10-12, 2018

Location: Riyadh International Exhibition Center, Riyadh, Saudi Arabia

Description: The show is a three-day exhibition and conference, showcasing the latest products, technology and services that the sector has to offer. This is the only event with the full support of the Ministry of Health and will cover the full spectrum of healthcare. The show is still young and this would be the third year running.

Website: https://www.globalhealthsaudi.com/en/home.html

Name of event: Saudi-American Healthcare Forum

Dates: April 1-2, 2019

Location: The Ritz Carlton Hotel & Conference Center, Riyadh, Saudi Arabia

Description: The conference is a three-day high-powered event focusing on various healthcare themes and issues and drawing on high level officials and executives from both the public and private sectors in the U.S. and Saudi Arabia.

Website: http://www.sahf2030.com/

FAQs

1. What is SAGIA and how does it support U.S. healthcare companies?

SAGIA is the government agency that is responsible for providing an attractive and lucrative investment environment for investors in order to promote investment in the Kingdom of Saudi Arabia, thereby expanding the economic landscape. SAGIA is the first line of contact for any U.S. healthcare company that is seeking to invest in the Kingdom because SAGIA can provide information for U.S. companies on the Kingdom’s investment climate and investor requirements.

2. Do U.S. manufacturers require a partner to operate in Saudi Arabia?

U.S. manufacturers may operate with or without a partner. To be eligible for 100% foreign ownership, particular requirements must be met, which can be sought from SAGIA. Any company with a foreign investment license will enjoy all of the privileges of a local Saudi company.

3. What are Saudi Arabia’s healthcare priorities over the next 3-5 years?

A Healthcare Investment Plan has been developed that identifies more than 40 opportunities for healthcare investment in different areas, among which include service provision, education and training, medical device manufacturing, pharmaceuticals manufacturing, support services, and digital and Information management. The recent National Transformation program also highlighted a number of initiatives and programs for the healthcare sector.

4. Is there a government-to-government collaboration in the area of healthcare?

U.S.-Saudi bilateral healthcare cooperation is robust. The Saudi Ministry of Health and the U.S. Department of Health and Human Services renewed an umbrella memorandum of understanding in September 2015. That broad agreement is currently supporting the two healthcare systems through additional data sharing, research collaboration, disease surveillance and infection control, subject matter experts exchange and training, and joint leadership to enhance global capacity to fight all types of biological threats under our common Global Health Security Agenda.

Local Associations

  • Saudi Association for Health Informatics (SAHI)
  • Saudi Association for Clinical Chemistry
  • Saudi Dental Society
  • Saudi Diabetes & Endocrine Association
  • Saudi Heart Association
  • Saudi Association for Venous Thrombo-Embolism
  • Saudi Pediatric Pulmonology Association
  • Saudi Lung Cancer Association
  • Saudi Oncology Society
  • Saudi Urology Association
  • Saudi Orthopedic Association
  • Saudi Association for Pulmonary Hypertension
  • The Saudi Healthcare Architects

Government Links

Best Prospects

  • Medical Devices: The Saudi market for medical equipment is estimated at just under $2 billion and is growing annually at roughly 10%. Greater awareness of health issues and a growing consumption of healthcare services sustain a strong market for medical equipment. Saudi Arabia is encouraging and offering a number of incentives for domestic manufacturing for these devices and instruments but currently manufactures low value commodities such as bandages, gloves, syringes and furniture. Imports represent approximately 98% of the market, with American products accounting for 21% of total imports.

Opportunities:

  • Emergency room equipment
  • Rehabilitation equipment
  • Diagnostic equipment
  • Electro-medical equipment
  • Orthopedic, dental appliances, and prosthesis
  • Glucometers
  • Implants

Web Resources

Events

Global Health Exhibition, September 10-12, 2018, Riyadh, Saudi Arabia

Arab Health, January 28 – 31, 2019, Dubai, UAE

  • Pharmaceuticals Sector: The Kingdom of Saudi Arabia accounts for 59.4% the purchases of pharmaceuticals products in the Gulf region. The market was estimated at $5.75 billion in 2017 and poised to grow at CAGR 6.7%, expected to reach $8.46 billion by 2023, according to a report published by Precision Business Insights. Saudi Arabia’s Vision 2030 and the NTP’s priorities for job creation and economic diversification provided a strong incentive for both the private and public sector to develop the life sciences industry in general, and pharmaceuticals in particular. Currently, only 30% of pharmaceutical products are manufactured locally. Major factors affecting the pharmaceutical market are the Kingdom’s growing population, the increase in per capita spending on healthcare services, and the propensity to prefer research-based products as opposed to purchasing more expensive patented products. However, in recent years, the SAG’s efforts to curb pharmaceuticals expenditure and promote local manufacturing resulted in a fast and growing generics market. European, U.S., and Indian companies already have established production facilities – especially, at the King Abdullah Economic Industrial Valley – producing a full range of products including antibiotics, diabetic treatments, cardiovascular drugs, and anticoagulants. Opportunities abound for additional manufacturers to establish a presence in the Kingdom, especially in vaccines, APIs, injectables, and biologics.

Sub-Sector Best Prospects

Pharmaceuticals for diabetic care, cardiovascular, antibiotics, and cancer treatment offer the best prospects.

Opportunities

With the change in the Saudi Arabia trade paradigm that is focusing more on job creation and economic diversification, the export and shipping of pharmaceutical products into the Saudi market no longer translates into commercial success. Local production, technology transfer, conducting clinical trials locally, and the training/education of the Saudi labor force are becoming the new normal in the life sciences/pharmaceutical products industry. The 2030 Vision and NTP has placed the Industrial Clusters (IC) as the leader government entity to develop five industrial sectors including the pharmaceutical and biotech industry.

Accordingly, the IC has identified the following opportunities in the pharmaceuticals industry:

  • Biologics and Biosimilars
  • Vaccine Formulation Fill and Finish (FFF)
  • Sterile Injectables (SI)
  • Solid Oral Dosage
  • Active Pharmaceuticals Ingredients (API)
  • Plasma Production
  • Bioequivalence Testing Center

Web Resources

U.S. Commercial Service Contact Information

Name: Maher Siblini (Sector Lead)

Position: Senior Commercial Specialist

Email: maher.siblini@trade.gov

Phone: +966.11.488.3800 x 4302

Name: Anwar Shaqhan

Position: Commercial Specialist

Email: anwar.shaqhan@trade.gov

Phone: +966.12.667.0080 x 4259

Name: Mohammed Shujauddin

Position: Commercial Specialist

Email: mohammed.shujauddin@trade.gov

Phone: +966.13.330.3200 x 3137

Statistics Snapshot

Market Size

Healthcare spending (including investment)

US$ 34.4 billion

... as percent of GDP

5.3 % of GDP

... of which spent on pharmaceuticals/consumables

$7.4 billion

Hospitals, Procedures, Healthcare Professionals UN

 

Number of hospitals

475

…Public

330

…Private

145

Number of hospital beds

70,092

... available beds per capita

2.2

...of which in general hospitals

51,100

Number of surgical procedures

1,144.9

Physicians

86,106

Dentists

13,957

Demographics

 

Population

32.2

Life expectancy men/women

73.3/75.9

Infant mortality/000

7.7

Percent of population older than 65

3.0

Annual deaths

3.7 deaths/1,000 population

Ischemic heart disease

19.6%

Stroke

14.4%

Diabetes mellitus

4.2%


  Notice to Visitors!


  The link you have chosen will take you to a non-U.S. Government website.

  If the page does not appear in 5 seconds, please click this: outside web site

  Export.gov is managed by the International Trade Administration and external links are covered by its website  disclaimer statement.


  Notice to Visitors!


  The link you have chosen will take you to a non-U.S. Government website.

  If the page does not appear in 5 seconds, please click this: outside web site

  BuyUSA.gov is managed by the International Trade Administration and external links are covered by its website disclaimer statement.